Importantly, we found that METTL3 was markedly reduced in sorafenib‐resistant HepG‐2 cells with consistently decreased global RNA m6A level (Fig 1H and I), indicating a potential role of METTL3 in mediating resistance toward sorafenib in HCC cells. The gene discussed is METTL3; the disease is hepatocellular carcinoma.